Salix Pharma Reports Q1 EPS of $0.34 vs. $0.18 Estimate; Revenues $105.9M vs. $107.9M Estimate (SLXP)

by Benzinga Staff

May 5, 2011 4:19 PM | 6 seconds read | Make a Comment

Salix Pharma

SLXP

Reports Q1 EPS of $0.34 vs. $0.18 Estimate; Revenues $105.9M vs. $107.9M Estimate.

Posted In: Earnings News Health Care Pharmaceuticals

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.